Curcumin

Research summaries and information about curcumin — its biochemistry, preclinical findings, and role in combination protocols.

3 Articles

Curcumin Research

Curcumin & Cancer: Human and Preclinical Evidence

Curcumin, the active compound in turmeric, has been widely studied for its biological effects. A 2024 Frontiers in Oncology review highlights its potential role in cancer research and metabolic health.

Curcumin Research

Curcumin and Cancer Research: Key Mechanisms Explained

Curcumin, the main bioactive polyphenol found in turmeric (Curcuma longa), has been widely studied for its biological activity, particularly in the context of cancer-related research. A comprehensive scientific review published in Anticancer Research.

Protocols Fenbendazole Ivermectin

ISOM Protocol: Metabolic Strategy with Repurposed Drugs

The ISOM Hybrid Orthomolecular Protocol is a science-based cancer treatment framework combining repurposed drugs (fenbendazole, ivermectin), orthomolecular medicine, and metabolic therapy. Developed by ISOM researchers including Dr. William Makis.

In-depth research on repurposed drugs, experimental cancer protocols, and integrative oncology — helping patients and practitioners make informed decisions.

Success! Your email is updated.

Your link has expired

Success! Your account is fully activated, you now have access to all content.

Curcumin

Curcumin & Cancer: Human and Preclinical Evidence

Curcumin and Cancer Research: Key Mechanisms Explained

ISOM Protocol: Metabolic Strategy with Repurposed Drugs

Subscribe to see what we're thinking

Great!